BRIEF-FDA approves Genentech's MS drug Ocrevus
* FDA approves Genentech's Ocrevus (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
Nov 30 Nikkei:
* Sekisui House will purchase and redevelop the Washington headquarters of American mortgage buyer Fannie Mae - Nikkei
* Sekisui House likely will pay 10 billion yen to 20 billion yen for the building - Nikkei
* Sekisui House plans to remodel the building into a shopping center, to build luxury condominiums on vacant land - Nikkei Source text: (s.nikkei.com/2fRpXAV) Further company coverage:
LIMA, March 28 A Boeing jet operated by Peruvian Airlines caught fire on Tuesday while landing at an airport near the Andean town of Jauja in central Peru after it swerved on the runway, but there were no serious injuries, a government minister said.
March 28 The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay by regulators over manufacturing issues.